Clinical trial
Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and…
NCT00468130 · University of Medicine and Dentistry of New Jersey, Other · Completed
Key facts
| NCT number | NCT00468130 |
|---|---|
| Title | Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children |
| Official title | Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children |
| Acronym | Abilify |
| Lead sponsor | University of Medicine and Dentistry of New Jersey, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Autism |
| Intervention type | Drug |
| Interventions | Aripiprazole, Placebos |
| Enrollment | 13 |
| Start date | May 1, 2006 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | May 2, 2007 |
| Last update posted | Jan 14, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: